CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
CRVS holding history
Corvus Pharmaceuticals, Inc. in every 13F filed by CHI Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVS overviewAll 13F holders of CRVSFull Q3 2023 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −200,000−100.0% | Sold out | Holders |
| Q2 2023 | 200,000 | $458.0K | 0.1% | −2,139,402−91.5% | Reduced | Holders |
| Q1 2023 | 2,339,402 | $2.13M | 0.6% | −45,000−1.9% | Reduced | Holders |
| Q4 2022 | 2,384,402 | $2.03M | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,384,402 | $1.95M | 0.5% | +170,218+7.7% | Added | Holders |
| Q2 2022 | 2,214,184 | $2.19M | 0.8% | +511,047+30.0% | Added | Holders |
| Q1 2022 | 1,703,137 | $2.79M | 1.2% | +1,303,137+325.8% | Added | Holders |
| Q4 2021 | 400,000 | $964.0K | 0.3% | +234,073+141.1% | Added | Holders |
| Q3 2021 | 165,927 | $803.0K | 0.2% | −553,205−76.9% | Reduced | Holders |
| Q2 2021 | 719,132 | $1.92M | 0.4% | +40,000+5.9% | Added | Holders |
| Q1 2021 | 679,132 | $2.09M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.